Medication6 min read

How GLP-1 medications actually work

GLP-1 medications can feel mysterious — appetite quietens, meals feel smaller, the scale moves. But the mechanism is well understood. These drugs copy a hormone your own body releases every time you eat.

A hormone you already make

GLP-1 — glucagon-like peptide-1 — is a hormone the gut secretes after a meal. It's part of how the body coordinates digestion, blood sugar, and the feeling of having eaten enough.

Medications like semaglutide and tirzepatide are GLP-1 receptor agonists: they bind the same receptors as the natural hormone, but they're engineered to last for days rather than minutes, so the signal stays steady.

Three things the medication does

The weight-loss effect comes from a few actions working together:

Slows stomach emptying, so food stays longer and you feel full sooner and for longer.
Acts on appetite centres in the brain, turning down hunger and 'food noise'.
Helps the pancreas release insulin in response to meals, steadying blood sugar.

Why the dose climbs slowly

Prescribers start low and step the dose up over weeks or months. That titration isn't caution for its own sake — a slower ramp gives the gut time to adjust and is the main lever for keeping side effects manageable.

It also means the strongest appetite effect usually arrives gradually, not on day one.

Semaglutide, tirzepatide, and the rest

Semaglutide acts on the GLP-1 receptor. Tirzepatide acts on two receptors — GLP-1 and GIP — which is part of why its trials have shown larger average weight loss.

Different brands, strengths, and schedules exist, and the right one is a clinical decision. The underlying biology, though, is the same family of effects.

What the trials found

In the STEP 1 trial, adults taking weekly semaglutide alongside lifestyle support lost roughly 15% of their body weight on average over 68 weeks. In SURMOUNT-1, tirzepatide produced average losses around 20% at its higher doses.

Averages hide a wide range — some people lose more, some less — but the trials confirm these are genuinely effective medications, not appetite tricks.

The short version

GLP-1 drugs mimic a natural gut hormone that signals fullness.
They slow stomach emptying, reduce appetite, and steady blood sugar.
The dose is raised slowly to keep side effects tolerable.
Landmark trials show average weight loss of roughly 15–20%.

Sources

1.Drucker DJ. Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1. Cell Metabolism (2018).Review of GLP-1 physiology and receptor-agonist mechanism.
2.Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine (2021).The STEP 1 trial — ~15% average weight loss with semaglutide.
3.Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine (2022).The SURMOUNT-1 trial — ~20% average weight loss with tirzepatide.
4.U.S. FDA Prescribing Information for semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro).Approved indications, titration schedules, and reported adverse events.

This is general education, not medical advice. It can't account for your individual history — decisions about your medication, dose, and care belong with you and your prescriber.